VDR-stromal reprogramming weakens the capacity of the PSCs to support cancer growth via stromal remodeling, alters the PSC phenotype to a more quiescent nature, and ultimately reduces fibrotic content and increases tumor vasculature [11]. This evidence concerns the gene VDR and neoplasm.